Press Release

Teva Invites Public to Listen to Webcast of Investor Meeting

Jerusalem, March 18, 2010 - Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) will host a live audio webcast of its investor meeting discussing Teva's planned acquisition of ratiopharm on Friday, March 19, 2010, at 1:00 p.m. ET.

What: Teva's Planned Acquisition of ratiopharm

Who: Teva Management

When: Friday, March 19, 2010, at 1:00 p.m. ET

Where: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=73925&eventID=2964296

How: Live over the Internet - log onto the Web at the address above and register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva's Web site.

About Teva
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 15 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative pharmaceuticals and active pharmaceutical ingredients. Over 80 percent of Teva's sales are in North America and Western Europe.

Company Contacts:

Investors
Elana Holzman
Teva Pharmaceutical Industries
+972 3 926-7554

Kevin Mannix
Teva North America
+1 215 591-8912

Media
Yossi Koren
Teva Pharmaceutical Industries
+972 3 926-7687 or 914-8267

Denise Bradley
Teva North America
+1 215 591-8974